India's Sun Pharma is joining the trend to build a portfolio in Russia with a deal worth $60 million to buy control of a Russian drug producer.

Chinese authorities have halted drug manufacturing in the northern city of Shijiazhuang as part of a crackdown on pollution. The shuttering of the three plants…

German drugmaker Merck KGaA has opened the doors to its Nantong manufacturing facility that will produce pharmaceuticals for China’s Essential Drug List to…

The roll-out of Samsung Bioepis' biosimilar version of blockbuster immunology drug Enbrel is going so well that analysts think additional manufacturing…

Is India's government back-pedalling on plans to boost India's bulk drug and intermediate manufacturers--and so reduce reliance on imports from China?

Samsung Bioepis has submitted a biosimilar version of Roche's breast cancer blockbuster Herceptin in the EU, hard on the heels of rivals Biocon and Mylan.

Vietnam has been one of the fastest-growing economies in Asia in recent years, and Sanofi has just cut a deal to give it a stronger position in the market.

Government warns drugmakers could leave the UK if the country's separation from the EU drags on and is kept under wraps.

Abbott picked up Vietnamese drug manufacturer Glomed for an undisclosed price in a deal that gives the pharma giant two manufacturing facilities in that…

Manufacturing